Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$4,545,692
+$72,975 QoQ
Shares Held
12,553
-1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#887
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. AMGN ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
This page
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,545,692 | 12,553 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $4,472,717 | 12,712 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,250,447 | 12,986 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,765,959 | 13,345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,383,187 | 12,117 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,527,992 | 11,324 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $2,921,253 | 11,208 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,462,146 | 10,745 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,304,783 | 10,577 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,024,311 | 10,637 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,851,398 | 9,900 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,845,093 | 10,586 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,320,109 | 10,450 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,224,461 | 13,338 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,135,396 | 11,938 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,720,578 | 12,070 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,949,769 | 12,124 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,123,347 | 12,916 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,888,839 | 12,841 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,596,881 | 12,212 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,687,831 | 11,027 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,738,154 | 11,005 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,442,440 | 10,623 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,553,037 | 10,045 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,421,574 | 10,267 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,057,304 | 10,148 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||